Join to View Full Profile
500 University DrHershey, PA 17033
Phone+1 717-531-4034
Fax+1 717-531-0002
Dr. Hohl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1991- University of ChicagoFellowship, Hematology and Medical Oncology, 1987 - 1989
- University of ChicagoResidency, Internal Medicine, 1984 - 1987
Rush Medical College of Rush University Medical CenterClass of 1984
Certifications & Licensure
PA State Medical License 2014 - 2026
IA State Medical License 1991 - 2014
IL State Medical License 1984 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML Start of enrollment: 2001 Jun 01
- A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer Start of enrollment: 2003 Aug 01
- Safety Study of GPX-150 in Patients With Solid Tumors Start of enrollment: 2008 Jan 01
Publications & Presentations
PubMed
- Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej
Blood Transfusion = Trasfusione Del Sangue. 2024-11-01 - 3 citationsImpact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej
Leukemia Research. 2024-08-01 - 1 citationsThe addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.Emma G Guare, Cory M Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue
Transplant Infectious Disease. 2024-04-01
Journal Articles
- Inhibiting Geranylgeranyl Diphosphate Synthesis Reduces Nuclear Androgen Receptor Signaling and Neuroendocrine Differentiation in Prostate Cancer Cell ModelsRaymond Hohl, MD, The Prostate
Press Mentions
Essential Phase I Trials; Eliminating Cervical Cancer; Win for Focused UltrasoundNovember 28th, 2025- Machtay Named Cancer Institute Associate Director for Clinical ResearchSeptember 29th, 2020
- Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology AllianceAugust 25th, 2020
Grant Support
- Career Development ProgramNational Cancer Institute2007–2011
- Cell Signaling And Developmental PharmacologyNational Cancer Institute2009
- Cell SignalingNational Cancer Institute2005
- Core--Analytical Pharmacology LaboratoryNational Cancer Institute2003
- Trial Of Irinotecan In PTS With Abnormal Liver/Renal Function Or Prior Pelvic RADNational Center For Research Resources2000–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
